Cautions and Opportunities for Botanicals in COVID-19 Patients: A Comment on the Position of the French Agency for Food, Environmental and Occupational Health & Safety

J Altern Complement Med. 2020 Oct;26(10):851-853. doi: 10.1089/acm.2020.0266. Epub 2020 Sep 21.
No abstract available

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / virology
  • France
  • Government Agencies
  • Humans
  • Pandemics
  • Phytotherapy
  • Plant Extracts / adverse effects
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / virology
  • Policy
  • SARS-CoV-2

Substances

  • Plant Extracts